• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
    • Sports
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • Trump Administration
  • IN FOCUS
  • Opinion
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism & Unity
    • Faith, Freedom & Self-Reliance
    • Courage, Strength & Optimism
    • Equality, Not Elitism
    • Community & Family
    • Fairness & Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Authors Posts by Linda Johnson

    Linda Johnson

    In this Thursday, Feb. 28, 2013 photo, a Merck logo is placed on scientist's lab coat in West Point, Pa. Merck & Co. reports quarterly financial results before the market opens on Wednesday, Feb. 5, 2014. (AP Photo/Matt Rourke)
    Business

    Merck Q4 net drops 14 pct. on generic competition

    Linda Johnson -
    February 5, 2014 4:25 pm
    0
    NIH, drugmakers, foundations partner to find meds
    Business

    NIH, drugmakers, foundations partner to find meds

    Linda Johnson -
    February 4, 2014 8:16 pm
    0
    Pfizer breast cancer drug hits midstage study goal
    Business

    Pfizer breast cancer drug hits midstage study goal

    Linda Johnson -
    February 3, 2014 9:12 pm
    0
    FILE - This April 20, 2010, file photo,shows an exterior view of Amgen offices in Fremont, Calif.  Biotech drugmaker Amgen Inc. reports quarterly earnings on Tuesday, Jan. 28, 2014.AP Photo/Paul Sakuma, file)
    Business

    Amgen 4Q profit leaps 30 percent on higher sales

    Linda Johnson -
    January 29, 2014 12:26 am
    0
    FILE - In this Jan. 30, 2012 file photo, boxes of the drug Relpax, made by Pfizer, are displayed in Surfside, Fla. Pfizer reports quarterly results before the market open on Tuesday, Jan. 28, 2014. (AP Photo/Wilfredo Lee, File)
    Business

    Pfizer’s 4Q net plunges on charges, sales decline

    Linda Johnson -
    January 28, 2014 7:02 pm
    0
    Sales up, 4th-quarter net falls for Bristol-Myers
    Business

    Sales up, 4th-quarter net falls for Bristol-Myers

    Linda Johnson -
    January 24, 2014 10:48 pm
    0
    In this Tuesday, July 30, 2013, photo, large banners hang in an atrium at the headquarters of Johnson & Johnson in New Brunswick, N.J. Johnson & Johnson reports quarterly financial results before the market opens on Tuesday, Jan. 21, 2014. (AP Photo/Mel Evans)
    Business

    Johnson & Johnson’s 4Q profit rises 19 percent

    Linda Johnson -
    January 21, 2014 11:05 pm
    0
    Study: Wiser medication use could cut health costs
    Business

    Study: Wiser medication use could cut health costs

    Linda Johnson -
    June 19, 2013 2:54 pm
    0
    Myriad stock volatile after high court gene ruling
    News

    Myriad stock volatile after high court gene ruling

    Linda Johnson -
    June 13, 2013 8:42 pm
    0
    High court ruling on gene patents lifts Myriad
    Business

    High court ruling on gene patents lifts Myriad

    Linda Johnson -
    June 13, 2013 7:07 pm
    0
    1...345...12Page 4 of 12
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism & Unity
    • Faith, Freedom & Self-Reliance
    • Courage, Strength & Optimism
    • Equality, Not Elitism
    • Community & Family
    • Fairness & Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter